January 15, 2026 · PRODUCTS
Neurosurgical robot with 0.5mm positioning accuracy supporting nearly 100 procedures across 12 categories including DBS and hematoma aspiration; per Frost & Sullivan's 2023 report, Remebot holds 52.6% share of China's neurosurgical robot market.
›January 15, 2026 · COMPANIES
Pioneer Chinese medical imaging company established in 1986, developing CT, MRI, and neurosurgical navigation systems for over 10,000 hospitals.
›January 15, 2026 · PRODUCTS
World's first 3D structured light neurosurgical robot with FDA and NMPA approval, developed by Sinovation for stereotactic brain surgery.
›January 15, 2026 · COMPANIES
Chinese neurosurgical robotics leader with FDA-approved 3D structured light robot systems and broad brain disease treatment solutions.
›January 15, 2026 · COMPANIES
Shanghai-based surgical robotics subsidiary of United Imaging Group, developing neurosurgical robots and percutaneous intervention systems.
›January 15, 2026 · PRODUCTS
NMPA-approved neurosurgical navigation and positioning system by UI Surgical with multimodal imaging fusion and AI-powered lesion analysis.
›January 15, 2026 · PRODUCTS
Integrated intelligent neurosurgical robot by UI Surgical for stereotactic procedures including DBS, SEEG, and brain biopsies.
›January 15, 2026 · PRODUCTS
Integrated brain and spine surgical robot combining neurosurgical positioning, navigation, and spinal robot guidance in one system; described by Sinovation as a domestic first in this combined configuration.
›